149 related articles for article (PubMed ID: 19883227)
1. Radiotherapy in conjunction with 7-hydroxystaurosporine: a multimodal approach with tumor pO2 as a potential marker of therapeutic response.
Khan N; Mupparaju SP; Hou H; Lariviere JP; Demidenko E; Swartz HM; Eastman A
Radiat Res; 2009 Nov; 172(5):592-7. PubMed ID: 19883227
[TBL] [Abstract][Full Text] [Related]
2. A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01.
Eastman A; Kohn EA; Brown MK; Rathman J; Livingstone M; Blank DH; Gribble GW
Mol Cancer Ther; 2002 Oct; 1(12):1067-78. PubMed ID: 12481430
[TBL] [Abstract][Full Text] [Related]
3. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
[TBL] [Abstract][Full Text] [Related]
4. Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry.
O'Hara JA; Goda F; Demidenko E; Swartz HM
Radiat Res; 1998 Nov; 150(5):549-56. PubMed ID: 9806597
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.
Hou H; Mupparaju SP; Lariviere JP; Hodge S; Gui J; Swartz HM; Khan N
Radiat Res; 2013 Mar; 179(3):343-51. PubMed ID: 23391148
[TBL] [Abstract][Full Text] [Related]
6. 7-hydroxystaurosporine (UCN-01) and ionizing radiation combine to inhibit the growth of Bcl-2-overexpressing U937 leukemia cells through a non-apoptotic mechanism.
Cartee L; Sankala H; Davis C; Smith R; Maggio S; Lin PS; Dent P; Grant S
Int J Oncol; 2002 Aug; 21(2):351-9. PubMed ID: 12118331
[TBL] [Abstract][Full Text] [Related]
7. Repeated tumor oximetry to identify therapeutic window during metronomic cyclophosphamide treatment of 9L gliomas.
Mupparaju S; Hou H; Lariviere JP; Swartz H; Jounaidi Y; Khan N
Oncol Rep; 2011 Jul; 26(1):281-6. PubMed ID: 21503586
[TBL] [Abstract][Full Text] [Related]
8. The effect of UCN-01 (7-hydroxystaurosporine), a potent inhibitor of protein kinase C, on fractionated radiotherapy or daily chemotherapy of a murine fibrosarcoma.
Tsuchida E; Urano M
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1153-61. PubMed ID: 9392558
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of 7-hydroxystaurosporine (UCN-01) and other staurosporine analogs to abrogate cisplatin-induced cell cycle arrest in human breast cancer cell lines.
Lee SI; Brown MK; Eastman A
Biochem Pharmacol; 1999 Dec; 58(11):1713-21. PubMed ID: 10571245
[TBL] [Abstract][Full Text] [Related]
10. [Abrogation of radiation-induced G2 arrest and radiosensitization by 7-hydroxystaurosporine (UCN-01) in human nasopharyngeal carcinoma cell line].
Hui ZG; Li YX; Yang WZ; Wu JX; Yu ZH
Ai Zheng; 2003 Jan; 22(1):6-10. PubMed ID: 12561427
[TBL] [Abstract][Full Text] [Related]
11. EPR Oximetry for Investigation of Hyperbaric O2 Pre-treatment for Tumor Radiosensitization.
Williams BB; Hou H; Coombs R; Swartz HM
Adv Exp Med Biol; 2016; 923():367-374. PubMed ID: 27526165
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of radiation cytotoxicity by UCN-01 in non-small cell lung carcinoma cells.
Mack PC; Jones AA; Gustafsson MH; Gandara DR; Gumerlock PH; Goldberg Z
Radiat Res; 2004 Dec; 162(6):623-34. PubMed ID: 15548112
[TBL] [Abstract][Full Text] [Related]
13. Synergistic combination of hyperoxygenation and radiotherapy by repeated assessments of tumor pO2 with EPR oximetry.
Hou H; Dong R; Lariviere JP; Mupparaju SP; Swartz HM; Khan N
J Radiat Res; 2011; 52(5):568-74. PubMed ID: 21799293
[TBL] [Abstract][Full Text] [Related]
14. [Abrogation effect of UCN-01 on radiation-induced G2 phase arrest of tumor cells and its mechanism].
Hui ZG; Li YX; Yang WZ; Yu ZH
Ai Zheng; 2005 Jan; 24(1):1-6. PubMed ID: 15642191
[TBL] [Abstract][Full Text] [Related]
15. Changes of oxygen tension in experimental tumors after a single dose of X-ray irradiation.
Goda F; O'Hara JA; Rhodes ES; Liu KJ; Dunn JF; Bacic G; Swartz HM
Cancer Res; 1995 Jun; 55(11):2249-52. PubMed ID: 7757972
[TBL] [Abstract][Full Text] [Related]
16. A Multimodal Molecular Imaging Study Evaluates Pharmacological Alteration of the Tumor Microenvironment to Improve Radiation Response.
Takakusagi Y; Naz S; Takakusagi K; Ishima M; Murata H; Ohta K; Miura M; Sugawara F; Sakaguchi K; Kishimoto S; Munasinghe JP; Mitchell JB; Krishna MC
Cancer Res; 2018 Dec; 78(24):6828-6837. PubMed ID: 30301838
[TBL] [Abstract][Full Text] [Related]
17. UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery.
Abe S; Kubota T; Otani Y; Furukawa T; Watanabe M; Kumai K; Akiyama T; Akinaga S; Kitajima M
Jpn J Cancer Res; 2001 May; 92(5):537-45. PubMed ID: 11376563
[TBL] [Abstract][Full Text] [Related]
18. Combined antitumor activity of 7-hydroxystaurosporine (UCN-01) and tamoxifen against human breast carcinoma in vitro and in vivo.
Koh J; Kubota T; Koyama T; Migita T; Hashimoto M; Hosoda Y; Kitajima M
Breast Cancer; 2003; 10(3):260-7. PubMed ID: 12955040
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines.
Playle LC; Hicks DJ; Qualtrough D; Paraskeva C
Br J Cancer; 2002 Jul; 87(3):352-8. PubMed ID: 12177808
[TBL] [Abstract][Full Text] [Related]
20. The pO2 in a murine tumor after irradiation: an in vivo electron paramagnetic resonance oximetry study.
O'Hara JA; Goda F; Liu KJ; Bacic G; Hoopes PJ; Swartz HM
Radiat Res; 1995 Nov; 144(2):222-9. PubMed ID: 7480649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
